Last month, Beckman Coulter, Inc., of Fullerton, California, announced that it will acquire the research flow cytometry instrumentation business of Dako Denmark A/S, of Glostrup, Denmark. The move strengthens Beckman’s product line in the research market. Sale of Dako’s flow cytometry division, which is based in Fort Collins, Colorado, is a step to concentrate efforts on molecular diagnostics. Patrik Dahlen, President and CEO of Dako, stated “This action reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics.”
INVERNESS BUYS PARADIGMHEALTH
It’s been a busy year for Inverness Medical Innovation, Inc., of Waltham, Massachusetts. On November 26, it announced the purchase of ParadigmHealth, Inc., of Upper Saddle River, New Jersey, in a deal valued at $230 million. ParadigmHealth is a “provider and integrator of care and disease management services for acutely ill and clinically complex patients, including neonatal intensive care and oncology patients.” Inverness is pursuing a corporate strategy of “near-patient diagnosis, monitoring and health management. It has a growing portfolio of diagnostics products.
ADD TO: Inverness
Earlier this year, Inverness Medical outbid Beckman Coulter to acquire Biosite, Inc. for $1.6 billion in a lengthy acquisition battle.(See TDR, June 4, 2007.) During 2007, Inverness also acquired Alere Medical Inc. ($302 million—disease management and patient monitoring), Matritech, Inc., ($36 million—cancer testing), HemoSense, Inc., ($165 million—POCT blood coagulation),Cholestech Corp. ($326 million—cholesterol testing), and Quality Assured Services Inc., ($25 million—home coagulation testing).
• Longtime lab industry executive Frank Kearns, M.S., MBA, died on December 1, 2007. In recent years, Kearns had served as CEO of Laboratory Alliance of Central New York, LLC, in Syracuse, New York. He also held executive positions with ARUP Laboratories, Inc., and SmithKline Beecham Clinical Laboratories, Inc., in a career that started in Southern California.
Dark Daily Update
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about…
…Google investing in 23andMe.com, an online business that offers a $999 genetic test to consumers, who purchase online, do the collection at home, and submit the specimen for testing.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.